Liver Cirrhosis: DR Alex Mogere

You might also like

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 51

LIVER CIRRHOSIS

DR ALEX MOGERE
CONSULTANT PHYSICIAN
Question.
Cirrhosis of the liver

• Final common pathway for many hepatic


disorders
Chronic cellular distruction
Fibrosis
regenerative nodules
Distortion of architecture
portal hypertention
Defn.
• A diffuse process characterized by liver necrosis and fibrosis and
conversion of normal liver architecture into structurally abnormal
nodules that lack normal lobular organization(WHO)
Cirhosis of the liver cont…..

• Classification:
 micronodular (ETOH)
 Macronodular (viral)
Other Causes of cirrhosis cont…..

• Sarcoidosis
• Drugs (eg Methotrexate)
• Glycogen storage disorder
Primary biliary cirrhosis
• Strong female preponderance .
• Median age of around 50 years at the time of diagnosis.
• X-terized by portal inflammation and necrosis of cholangiocytes in small- and medium-
sized bile ducts.
• Antimitochondrial antibodies (AMA) are present in about 90% of patients with PBC.
• Most pts are asymptomatic at Dx.
• Cholestatic liver enzyme abnormalities with an elevation in GGT and ALP along with mild
elevations in aminotransferases (ALT and AST)
• Liver transplantation is the Tx of choice for pts with decompensated cirrhosis due to PBC
• UDCA is the only approved Tx that has some degree of efficacy by slowing the rate of
progression of the disease.
Pathology in liver cirrhosis
• Nodularity-regenerating nodules
• Fibrosis-deposition of dense fibrous septa
• Hepatocytes: abnormalities(pleomorphism, dysplasia, hyperplasia)
• Grossly: irregular surface, firm
Clinical presentation

• General decline in health.


• Non specific complaints
• Anorexia,weight loss, fatigue, malaise,weakness
• Advanced stages present with:
Complication of portal hypertension
Clinical Presentation Conti…..

• Endocrine:
Diabetes mellitus
Gynaecomastia
Palmar erythema
Pulmonary
Hypoxaemia, Pleural effusion, hepato pulmonary
syndrome
Cont. Clinical presentation ..

• Hemorrhagic tendency;
menorrhagia,purpura,epistaxis
• Renal
Renal failure 2nd degree
Hepato renal syndrome 1
Hepatic encephalopathy
Palmar erythema
Anemia in cirrhosis
Patients may be anemic either from:
• chronic GI blood loss,
• nutritional deficiencies, or
• hypersplenism related to portal hypertension, or
• as a direct suppressive effect of alcohol on the bone marrow.
• Zieve’s syndrome(unique hemolytic anemia)
Suspect liver cirrhosis if
Labs;
• Chronic abnormal amino transferases
• Low alb <3.8g/dl
• Prolonged prothrombin time ,INR> 1.3
• Raised bilirubin
• Portal htn- thrombocytopenia
• AST/ALT >1
p/e
• Small liver span
• Splenomegaly
• Palpable left lobe of liver
• Stigmata of CLD; palmar erythema, muscle wasting,etc
• Signs of decompensation; ascites, asterixis, JN
Diagnosis Of Liver cirrhosis

• Lab Tests:
LFTS -may be normal
Coagulation profile( INR, PTI, )
U/E/C
Albumin and serum protein
TBC:- platelet count, Anaemia
Viral Markers: HBV, HCV
ANA,
aSMA/AMA
Diagnosis of liver cirhosis

• Radiology:- U/S, CT scan , MRI, Doppler U/S,


ERCP/OGD
Diagnosis of liver cirrhosis conti…

• Liver biopsy
 gold standard: clue to underlying cause
 risk of bleeding
 Trans jugular approach
Complications of cirrhosis
Management

• Control of ascites
• Varices: beta blockers,banding,sclerotherapy
• Encephalopathy
• Screening for Hepatocellular carcinoma
• Liver Transplant
Cont.mx
• Wilson disease-penicillamine
• Hemochromatosis-phlebotomy
• Chronic viral hepatitis-antivirals
• Established cirrhosis-tx complications
• Maintenance of nutrition
• Liver transplantation
CONT. CHILD PUGH CLASSIFICATION

• One and two yr survival rates:

1 yr 2 yr
• Class A 100% 85%
• Class B 80% 60%
• Class C 45% 35%
Ascitis

• Defination: Pathological accumulation of fluid


within the peritoneal cavity
Causes of Ascitis:
• Chronic liver disease
• Peritoneal infections, Cirhosis, alcoholic hepatitis, carcinomatosis

• Heart failure
• Malignancy
Causes Of Ascitis conti….

• TB
• Fulminating Hepatic failure
• Pancreatitis
• Nephrogenous
• Billiary Ascitis
• Serositis
• MEIgs syndrome
Pathogenesis of Ascitis

• Portal Hypertension is prerequisite for ascites


formation in liver disease
• SAAG Raised >1.1gldl
• Peripheral arterial vasodilation theory
Clinical Presentation

• History helps evaluate cause of ascites


• Alcohol intake
• Hx of unprotected sex HBV, HCV
• Family Hx of wilsons, Hemachromatosis
Presentation symptoms and signs

• Jaundice, pedal edema


• G.I bleeding
• Encelephalopathy
• Wt loss – cancer
• Cardiomyopathy-Heart Dx,
• fever, night sweating -TB
Physical Examination

• DD of Ascitis
 Massive hepatomegaly
 Gaseous distention
 Pregnancy
 Intra abdominal masses
 Shifting dullness
 Puddle sign approx. 120mls
Stigmata of chronic liver disease

• Stigmata of chronic liver disease


Palmar erythema
gynaecomastia
splenomegally,
Spider Naevi
Lab Test

• Blood test: LFTS,TBC,U/E/C


Ascitis fluid testing, Microscopy,cultural
SAAG, Cytology, LAD, Glucose
Management

• Paracentecis- up for 5 litre


• Diuretics Furosemide and Spironolactone
Spontaneous Bacterial peritonitis
• Defination
• Ascitic fluid infection with pure growth of a single organism , ascitic
neutrophil count.250 cell/ul with no evidence of surgically correctable
cause
• Occurs in setting of liver disease, nephrotic syndrome

• Agents
o E.coli klebsiella pneumonae and pneumococcus most common
• anaerobes~ 1%
Clinical Features

85 % of patient SBP
• Fever
• Abdominal pain
• Change in mental status

Treatment
• Antibiotics when cell count is >250 cell/ micro litre before cultures result
• 3rd generation cephalosporins
• Fluroquinolones 5-10days
Treatment
Abx for empirical tx:
• Iv cefotaxime, amoxicillin –clavulanic acid
• Oral norfloxacin(uncomplicated peritonitis)
• No aminoglycosides
• Re-evaluate if ascitic fluid PMN count has not decreased by at least 25
% after 2 days of tx
• Min. duration of tx 5 /7
Hepato Renal Syndrome
• HRS is the final stage of functional renal impairment in pts with
cirhosis and PHT
• Occurs in refractory Ascitis
HRS is characterised by:
• Peripheral vasodilatation, creatinine clearance 40ml/min
• Normal intravascular volume
• Absence of intrinsic renal disease
• urine Na+ <10 mmol/L
HRS Treatment
• Withdraw : Diuretics and nephrotoxic agents
• Infuse saline and or albumin
• Vasoactive agents:- octreotide , talipresin
• TIPS
• liver transplantation only definitive cure
Chronic Hepatic Encephalopathy
• A complication of liver cirrhosis characterized by: mental/ neurological disturbances in presence of liver
failure.

Its Classified as:


• i.
acute (episodic);
persistent (chronic):
subclinical (minimal)

• ii.
Type C. (Cirhosis)
Type A (Acute Liver Failure)
 Type B ( porto systemic shunting)
Ammonia
• Neurotoxic generated in intestines
• Negative protein balance
avoid
• GI bleed
• Infection
• Renal Failure
Management
• Identify and tx ppt factor
• Lactulose titration
• Rifaxamine
• Metronidazole/neomycin
• Protein 1-2 g/kg/per day recommended
Portal hypertension
• defined as the elevation of the hepatic venous pressure gradient (HVPG)
to >5 mmHg.
Causes:
increased intrahepatic resistance to the passage of blood flow through
the liver due to cirrhosis and regenerative nodules
increased splanchnic blood flow secondary to vasodilation within the
splanchnic vascular bed
• Cause of ascites and variceal bleed
• Variceal h’ge is an immediate life-threatening prob with a 20–30%
mortality rate associated with @ episode of bleeding.
Ct portal hypertension: classification
THE END!

You might also like